Cargando…
Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma
Multiple myeloma (MM) is a cancer caused by uncontrolled proliferation of antibody-secreting plasma cells in bone marrow, which represents the second most common hematological malignancy. MM is a highly heterogeneous disease and can be classified into a spectrum of subgroups based on their molecular...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766463/ https://www.ncbi.nlm.nih.gov/pubmed/31572666 http://dx.doi.org/10.5306/wjco.v10.i9.303 |